Is the Push for AI Systems to Discover New Medicines Proving Effective for Researchers?

The realm of drug discovery is an intricate and time-consuming journey involving various experts, such as doctors, medical researchers, and chemists. The latter part of this process relies on chemists’ intuition, developed from years of experience in the field. A groundbreaking study reveals that artificial intelligence (AI) may dramatically cut the drug discovery process’s time […]

Continue Reading

AHA cautions that regular marijuana use may pose higher risks for heart and brain health

Two new studies reported by the American Heart Association (AHA) at their 2023 annual meeting suggest that regular marijuana use could be detrimental to the heart and brain, especially in older adults with existing medical conditions. The first study included 156,999 individuals with no known history of heart disease, of which 2,958 developed heart failure […]

Continue Reading

Synopsys broadens its processor design portfolio with the introduction of RISC-V ARC-V Family

Synopsys has announced plans to expand its processor intellectual property portfolio with the new RISC-V ARC-V family. The company is introducing designs for its next-generation ARC-V processor, using the RISC-V architecture, for chip applications in the embedded automotive, storage, and internet of things markets. The company revealed the new IP during the RISC-V North America […]

Continue Reading

OpenAI introduces customizable ‘GPTs’ for both businesses and consumers

OpenAI, the leading artificial intelligence research laboratory, has recently introduced a groundbreaking solution for businesses and consumers alike. The company has launched customizable AI agents known as GPTs, which enable users to create personalized versions of ChatGPT. With the release of GPTs, OpenAI aims to empower individuals and businesses to harness the power of AI […]

Continue Reading